Pricing

Optinose Inc (OPTN)

followers ·
Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Peter K. Miller
Employees:
190
1020 STONY HILL ROAD, SUITE 300, YARDLEY, PA, 19067
267-364-3500

Are you looking for this stock instead?

OptiNose, Inc. focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. Onzetra Xsail, a powder EDS device, is in Phase IIIb clinical trial.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available